You just read:

FDA Advisory Committee Recommends Approval Of Brodalumab For Treatment Of Moderate-To-Severe Plaque Psoriasis

News provided by

Valeant Pharmaceuticals International, Inc.

19 Jul, 2016, 16:27 ET